Influence of electrolyte and poloxamer 188 on the aggregation kinetics of solid lipid nanoparticles (SLNs)

Drug Development and Industrial Pharmacy

Volumn 38, Issue 9, 2012, Pages 1084-1089

  Wei, Cong Cong ^a   Ge, Zhi Qiang ^a  

^a TIANJIN UNIVERSITY   (China)

Author keywords

Critical coagulation concentration (CCC); DLVO theory; Electrostatic repulsion; Solid lipid nanoparticles (SLNs); Stability ratio; Steric stabilization

Indexed keywords

ELECTROLYTE; POLOXAMER; POLYMER; SODIUM CHLORIDE; SOLID LIPID NANOPARTICLE; SOLVENT;

ARTICLE; DISPERSION; EMULSION; LIGHT SCATTERING; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; THEORY;

ADHESIVENESS; COLLOIDS; DIFFUSION; DRUG CARRIERS; ELECTROLYTES; EXCIPIENTS; FATTY ACIDS, NONESTERIFIED; KINETICS; LIPIDS; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; NEPHELOMETRY AND TURBIDIMETRY; OSMOLAR CONCENTRATION; PALMITIC ACID; POLOXAMER; SODIUM CHLORIDE; STATIC ELECTRICITY; STEARIC ACIDS; SURFACE PROPERTIES; SURFACE-ACTIVE AGENTS;

EID: 84864438970     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2011.640331     Document Type: Article

References (27)

1. Muller RH, Keck CM. (2004). Challenges and solutions for the delivery of biotech drugs-a review of drug nanocrystal technology and lipid nanoparticles. J Biotechnol, 113:151-170.
2. Westesen K, Bunjes H. (1995). Do nanoparticles prepared from lipids solid at room temperature always possess a solid lipid matrix? Int J Pharm, 115:129-131.
3. Ghaffari S, Varshosaz J, Saadat A, Atyabi F. (2011). Stability and antimicrobial effect of amikacin-loaded solid lipid nanoparticles. Int J Nanomedicine, 6:35-43.
4. Mei ZN, Chen HB, Weng T, Yang Yj, Yang XL. (2003). Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Eur J Pharm Biopharm, 56:189-196.
5. zur Muhlen A, Schwarz C, Mehnert W. (1998). Solid lipid nanoparticles (SLN) for controlled drug delivery-drug release and release mechanism. Eur J Pharm Biopharm, 45:149-155.
6. Han F, Li SM, Yin R, Liu HZ, Xu L. (2008). Effect of surfactants on the formation and characterization of a new type of colloidal drug delivery system: Nanostructured lipid carriers. Colloids Surf A Physicochem Eng Asp, 315:210-216.
7. Trujillo CC, Wright AJ. (2010). Properties and stability of solid lipid particle dispersions based on canola stearin and Poloxamer 188. J Am Oil Chen Soc, 87:715-730.
8. Vivek K, Reddy H, Murthy RS. (2007). Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles. AAPS PharmSciTech, 8:E83.
9. Seetapan N, Bejrapha P, Srinuanchai W, Ruktanonchai UR. (2010). Rheological and morphological characterizations on physical stability of gamma-oryzanol-loaded solid lipid nanoparticles (SLNs). Micron, 41:51-58.
10. del Pozo-Rodriguez A, Solinis MA, Gascon AR, Pedraz JL. (2009). Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy. Eur J Pharm Biopharm, 71:181-189.
11. Freitas C, Muller RH. (1998). Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticles (SLNs) dispersion. Int J Pharm, 168:221-229.
12. Garcia-Fuentes M, Torres D, Alonso MJ. (2005). New surfacemodified lipid nanoparticles as delivery vehicles for salmon calcitonin. Int J Pharm, 296:122-132.
13. Zimmermann E, Muller RH. (2001). Electrolyte- and pH-stabilities of aqueous solid lipid nanoparticle (SLN) dispersions in artificial gastrointestinal media. Eur J Pharm Biopharm, 52:203-210.
14. Teeranachaideekul V, Muller RH, Junyaprasert VB. (2007). Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC) - effects of formulation parameters on physicochemical tability. Int J Pharm, 340:198-206.
15. Liu CH, Wu CT, Fang JY. (2010). Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery. Drug Dev Ind Pharm, 36:751-761.
16. Martins S, Tho I, Ferreira DC, Souto EB, Brandl M. (2011). Physicochemical properties of lipid nanoparticles: Effect of lipid and surfactant composition. Drug Dev Ind Pharm, 37:815-824.
17. Olbrich C, Kayser O, Muller RH. (2002). Enzymatic degradation of Dynasan 114 SLN - effect of surfactants and particle size. J Nanopart Res, 4:121-129.
18. Garcia-Fuentes M, Torres D, Alonso MJ. (2002). Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules. Colloids Surf B-Biointerfaces, 27:159-168.
19. Musoke M, Luckham PF. (2004). Interaction forces between polyethylene oxide-polypropylene oxide ABA copolymers adsorbed to hydrophobic surfaces. J Colloid Interface Sci, 277:62-70.
20. Stenkamp VS, Berg JC. (1997). The role of long tails in steric stabilization and hydrodynamic layer thickness. Langmuir, 13:3827-3832.
21. Chen XX, Matteucci ME, Lo CY, Johnston KP, Williams RO 3rd. (2009). Flocculation of polymer stabilized nanocrystal suspensions to produce redispersible powders. Drug Dev Ind Pharm, 35:283-296.
22. Chen KL, Mylon SE, Elimelech M. (2006). Aggregation kinetics of alginate-coated hematite nanoparticles in monovalent and divalent electrolytes. Environ Sci Technol, 40:1516-1523.
23. Holthoff H, Egelhaaf SU, Borkovec M, Schurtenberger P, Sticher H. (1996). Coagulation rate measurements of colloidal particles by simultaneous static and dynamic light scattering. Langmuir, 12:5541-5549.
24. Mylon SE, Chen KL, Elimelech M. (2004). Influence of natural organic matter and ionic composition on the kinetics and structure of hematite colloid aggregation: Implications to iron depletion in estuaries. Langmuir, 20:9000-9006.
25. Verwey EJW. (1948). Theory of the stability of lyophobic colloids. J Phys Chem, 51:631-636.
26. Jin ZL, Hou WG, Dai GL, Sun DJ, Zhang CG, Sun ZW. (2004). Effect of electrolytes on kinetic behavior of colloidal dispersions of Mg-Al hydrotalcite-like compounds. Acta Chim Sinica, 62:2025-2029.
27. Gast AP, Leible L. (1986). Interactions of sterically stabilized particles suspended in a polymer solution. Macromolecules, 19:686-691.